HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
Benzene, 1,3-dibromo-2-methoxy-
1,3-Dibromo-2-methoxybenzene · 2,6-DIBROMOANISOLE · 2,6-Dibromoanisole,>97% · 2,6-Dibromo-1-methoxybenzene · Benzene,1,3-dibroMo-2-Methoxy-
Identifikatoren & physikalische Daten
| CAS No. | 38603-09-7 |
|---|---|
| Summenformel | C7H6Br2O |
| Durchschnittliche Molmasse | 265,93 g/mol |
| Monoisotopische Masse | 263,87853901 g/mol |
| SMILES | COc1c(Br)cccc1Br |
| InChIKey | BMZVDHQOAJUZJL-UHFFFAOYSA-N |
| PubChem CID | 181584 |
| EC No. | 803-779-2 |
| DTXSID | DTXSID40191921 |
Chemische & physikalische Eigenschaften
| XLogP | 3,3 |
|---|---|
| Polarare Oberfläche (TPSA) | 9,2 |
| H-Brücken-Donoren | 0 |
| H-Brücken-Akzeptoren | 1 |
| Frei drehbare Bindungen | 1 |
| Schwere Atome | 10 |
| Formalladung | 0 |
| Komplexität | 97,8 |
| SpringerMaterials Properties | Nuclear quadrupole resonance spectroscopy |
| LogP (Verteilungskoeffizient) | 3.42 |
| Schmelzpunkt | 13°C |
| Siedepunkt | 254℃ |
| Dichte | 1.823 |
| Brechungsindex | 1.5920 to 1.5960 |
| Flammpunkt | 100℃ |
| Lagerbedingungen | Sealed in dry,Room Temperature |
| Aggregatzustand | clear liquid |
| Farbe | Colorless to Light yellow |
| Henry-Konstante | 3.7×10-2 mol/(m3Pa) at 25℃, Pfeifer et al. (2001) |
| InChI | InChI=1S/C7H6Br2O/c1-10-7-5(8)3-2-4-6(7)9/h2-4H,1H3 |
| InChIKey | BMZVDHQOAJUZJL-UHFFFAOYSA-N |
| SMILES | C1(Br)=CC=CC(Br)=C1OC |
| CAS Datenbank | 38603-09-7 |
Sicherheit & Vorschriften
| GHS-Einstufung | DangerH301 (95%): Toxic if swallowed [Danger Acute toxicity, oral]P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. |
|---|---|
| Hazard Classes and Categories | Acute Tox. 3 (95%) |
| Zollcode | 2909303840 |
Anwendungen & Verwendung
Verwenden
2,6-Dibromoanisole is an anisole compound containing a substituent bromine atom that can be used in bromine substitution reactions to prepare other organic ether derivatives. It is also a Lusutrombopag intermediate, which is used to treat thrombocytopenia (low platelets in the blood) in adult patients with chronic liver disease who are scheduled to undergo medical or dental procedures.